Tybost® (Cobicistat 150 mg) is a potent CYP3A inhibitor designed to boost the effectiveness of atazanavir or darunavir by increasing their systemic exposure when used in a once-daily regimen for HIV-1 treatment.
Each tablet is film-coated to enhance absorption and patient compliance.
This prescription medication is an essential component of a comprehensive antiretroviral therapy regimen, aiming to improve outcomes for individuals living with HIV-1.
